The Edit
The Edit publishes 2 rankable monthly figures and not one of them says what dose it buys. This site prints no comparable figure for The Edit, and the reading behind that is on this page.
Ellis Brandt built this site’s grading methodology and maintains it. Last re-read September 2026.
The figures this seller publishes
The Edit publishes 2 rankable monthly figures for semaglutide and tirzepatide. This site prints no comparable figure for The Edit, because a figure that does not say what dose it buys cannot be compared with one that does. What follows is what was read, in the words of the person who read it.
Semaglutide
The seller ties no dose to this figure.
No mg anywhere on this products index page. Pass-3's note cites a 'Same price at every dose' line from the product's own PDP — that is a DIFFERENT page and is not in this page unit, so it cannot make the tie here.
The page never says what the figure covers. Read September 2026 from https://theedithealth.com/products.html.
Tirzepatide
The seller ties no dose to this figure.
No mg anywhere on this products index page; nothing to tie and nothing adjacent.
The page never says what the figure covers. Read September 2026 from https://theedithealth.com/products.html.
What the page states, and what it leaves out
Talks about pharmacies and names none. No figure this seller publishes states what it buys, so no price is printed here.
Cancellation
Cancellation terms have not been read for The Edit. The pass that opened, timed and recorded cancellation terms covered the 60 sellers whose figure states what it buys, and The Edit is not one of them. This site therefore states nothing about how The Edit handles cancellation — not that terms are absent, only that we have not read them. It is a gap in this site’s reading, and it is recorded as one rather than scored as a silence.
Dose escalation
This seller does not print the titration steps its patients follow. 54 of the 60 sellers whose figure states what it buys do not either. What the four FDA-approved labels set as the escalation is published on this site with no provider named and no paid link.
Go to The Edit
The Edit pays this site nothing. The link below is unpaid and carries no tracking of any kind. It goes to the seller's own home page, because the page carrying the figure is not one a reader reaches directly.
Visit siteWhere this seller is listed
One board per buying decision. Each is the same table with the columns that decision needs, under its own dated and counted title.
- Semaglutide providers54 listed, September 2026
Readers who have settled on semaglutide and are choosing who to buy it from.
- Tirzepatide providers52 listed, September 2026
Readers who have settled on tirzepatide and are choosing who to buy it from.
- Providers that publish a price before the intake59 listed, September 2026
Readers who will not start an intake without seeing a standing rate and what it covers.
- GLP-1 providers with a published price, compared59 listed, September 2026
Readers whose first question is the number, and who want to see what each figure actually buys before comparing them.
- GLP-1 providers for readers paying cash52 listed, September 2026
Readers who are paying out of pocket and need the medication itself inside the published figure, not just the consult.
- GLP-1 telehealth providers60 listed, September 2026
Readers choosing a prescriber rather than a price — who dispenses, what the plan includes, and how to leave it.